Table 2.
Correlation between clinicopathological parameters and ARTN expression in a CRC patient cohort.
| Parameter | n | ARTN positive, n (%) | p value |
|---|---|---|---|
| Age | |||
| ≤55 | 36 | 23 (63.9%) | 0.835 |
| >55 | 53 | 35 (66.0%) | |
| Tumor size | |||
| ≤5 | 53 | 36 (67.9%) | 0.508 |
| >5 | 36 | 22 (61.1%) | |
| Lymph node metastasis | |||
| Absent | 33 | 14 (42.4%) | 0.001 |
| Present | 56 | 44 (78.6%) | |
| Grade | |||
| Well | 7 | 4 (57.1%) | 0.504 |
| Moderate | 43 | 26 (60.5%) | |
| Poor | 39 | 28 (71.8%) | |
| Stage | |||
| I + II | 34 | 17 (50%) | 0.018 |
| III+ IV | 55 | 41 (74.5%) | |
Chi-squared test. Values in bold are considered as significant (p < 0.05).